Pfizer Inc.'s stock is trading at $22 with an 8% dividend yield, driven by market fears over losing vaccine revenues. Read ...

Complex Pandemic Accord negotiations have been underway since 2021, with 13 formal meetings and numerous informal sessions.

A review of 600 US patients treated for suspected sepsis found 31.5% most likely didn't have a bacterial infection, while ...

Shares of several vaccine makers soared after reports suggest that the Biden administration is in discussions with Moderna MRNA and Pfizer PFE to set up a possible vaccine program aimed at preventing ...

The HHS chief, who has long argued that vaccines cause autism, dismissed the notion that "better diagnoses, better recognition, or changing diagnostic criteria" are driving up figures. Also, the CDC's ...

The health secretary is frequently returning to rhetoric from his time as one of the nation's most prominent vaccine critics.

Leerink Partners analyst David Risinger maintained a Sell rating on Moderna (MRNA – Research Report) yesterday and set a price target of ...